Skip to content

Delek US Holdings DK Proceeds from product and other financing agreements

Proceeds from product and other financing agreements at other companies

Calumet, Inc. logo
Calumet, Inc.CLMT
$40M+10.6%
Nuvation Bio logo
Nuvation BioNUVB
$864K
American Eagle Outfitters logo
American Eagle OutfittersAEO
$4.65M
MFA Financial logo
MFA FinancialMFA
$797.12M+134%
Syndax Pharmaceuticals logo
Syndax PharmaceuticalsSNDX
$0-100%
AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
$7.43M+120%

Other financials

Income statement

See full
Revenue$2.7B+0.4%
Gross profit-$130.2M-104%
Operating income-$179.3M-42.5%
Net income-$201.3M-16.6%
EPS (diluted)-$3.34-20.1%

Balance sheet

See full
Cash & equivalents$624.1M0.0%
Total debt$3.3B+3.9%
Total equity$302.0M-29.7%
Total assets$7.6B+10.0%

Cash flow

See full
Operating cash flow$461.1M+839%
CapEx$187.7M+38.3%
Free cash flow$273.4M+238%

Valuation

See full
Market cap$2.66B+189%
Enterprise value$5.29B+54.8%
P/S0.3×+0.2×

Profitability

See full
Gross margin5.1%+4.0pp
Operating margin2.3%+1.3pp
Net margin-0.5%-0.2pp
FCF margin4.5%+2.7pp

Returns & leverage

See full
Return on equity-14.1%-6.5pp
Debt / equity10.8×+3.5×
Current ratio0.8×-0.1×

Where this comes from

Reported directly by Delek US Holdings in its filing.

Tagged under the XBRL concept dk:ProceedsFromProductAndOtherFinancingAgreements.

The official record: Delek US Holdings’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Delek US Holdings's proceeds from product and other financing agreements.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Delek US Holdings's proceeds from product and other financing agreements?
Delek US Holdings (DK) reported proceeds from product and other financing agreements of $268.6M in Q1 2026.
How has Delek US Holdings's proceeds from product and other financing agreements changed year-over-year?
Delek US Holdings's proceeds from product and other financing agreements decreased by 25.8% year-over-year, from $362M to $268.6M.
What is the long-term trend for Delek US Holdings's proceeds from product and other financing agreements?
Over 4 years (2021 to 2025), Delek US Holdings's proceeds from product and other financing agreements has grown at a 22.6% compound annual growth rate (CAGR), from $916.1M to $2.07B.
What does proceeds from product and other financing agreements mean?
Represents cash inflows derived from specialized short-term or structured financing arrangements related to inventory or product supply chains. These agreements are often used by energy companies to optimize working capital by monetizing inventory assets through third-party intermediaries.